基于不同范式的脑电脑接口的应用在肌缩性侧面硬化症中的进展
Tong Li1, Yuling Gao1, Jiaqi Zhou1
1Department of Rehabilitation Medicine, The First Affiliated Hospital of Dalian Medical University, College of Health-Preservation and Wellness, Dalian Medical University, Dalian, China.
Frontiers in neuroscience
|December 24, 2025
概括
大脑-计算机接口 (BCI) 为患有肌缩侧面硬化症 (ALS) 的人提供了新的通信和控制. 本综述总结了BCI的应用,局限性以及ALS康复的未来前景.
科学领域:
- 神经科学与工程 神经科学与工程
- 辅助技术 辅助技术 辅助技术
- 医疗康复 医疗康复
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种进展性神经疾病,导致运动和沟通的丧失.
- 大脑-计算机接口 (BCI) 正在迅速发展,为个人与世界互动提供了新的途径.
- BCI为ALS患者提供了一种新的沟通和控制方法,提高了他们的生活质量.
研究的目的:
- 审查目前的大脑-计算机接口 (BCI) 应用程序的状态,用于肌缩侧面硬化症 (ALS).
- 总结BCI应用结果,确定局限性,并探索ALS的未来前景.
- 提供基于证据的参考资料,用于ALS康复中BCI技术的翻译.
主要方法:
- 在Web of Science和PubMed数据库的系统文献搜索.
- 遵守PRISMA指导方针进行研究选择.
- 纳入和排除标准用于确定23项相关研究.
主要成果:
- 总结了各种BCI范式在ALS运动控制和通信中的应用结果.
- 确定了针对ALS的BCI技术当前的局限性和挑战.
- 突出了多模式融合和适应性校准的前景,以提高BCI性能.
结论:
- 在改善ALS患者的沟通和控制方面,BCI技术显著有前途.
- 需要进一步取得进展,以克服现有的障碍,并提高BCI的有效性.
- 多模式融合和适应性校准是未来ALS康复中BCI开发的关键领域.
更多相关视频
09:42Author Spotlight: Using Motor Imagery Brain-Computer Interface to Improve Motor and Cognitive Function in Stroke Patients
Published on: September 1, 2023
2.0K
06:11Brain-Computer Interface-controlled Upper Limb Robotic System for Enhancing Daily Activities in Stroke Patients
Published on: April 18, 2025
1.5K
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...